Editing Agilent Technologies (section)

===2010 onwards===
In 2009, Agilent announced the closure of a subsection of its Test & Measurement division. The product lines affected included the automated optical inspection, [[solder paste]] inspection, and automated {{nowrap|X-ray}} products [5DX] in 2004. In 2011, the company, along with the [[University of California, Davis]], announced that it would be establishing the "Davis Millimeter Wave Research Center".<ref>{{cite news |url = http://www.eetimes.com/document.asp?doc_id=1264252 |title = Agilent and UC Davis form millimeter research center |last = Mokhoff|first = Nicolas|date = 3 August 2011|work = EE Times|access-date = 2015-07-28|location = San Francisco, California|url-status = live |archive-url = https://web.archive.org/web/20151016221251/http://www.eetimes.com/document.asp?doc_id=1264252 |archive-date = 16 October 2015 }}</ref> Agilent announced it would increase its life sciences engagement through the acquisition of Halo Genomics, based in [[Uppsala]], Sweden, which was involved in [[next-generation sequencing]] technology development.<ref name="dddmag2011">{{cite press release|date = 7 December 2011|title = Agilent Acquires Two Life Science Companies|publisher = Agilent Technologies|access-date = 2015-07-28|url = http://www.dddmag.com/news-Agilent-Acquires-Two-Life-Science-Companies-12711.aspx|via = Drug Discovery & Development|url-status = dead|archive-url = https://web.archive.org/web/20120211061518/http://www.dddmag.com/news-Agilent-Acquires-Two-Life-Science-Companies-12711.aspx|archive-date = 2012-02-11}}</ref>

On May 17, 2012, Agilent agreed to buy Dako, a Danish cancer diagnostics company, for $2.2 billion, to expand its presence in the life sciences industry.<ref>{{cite news|url = https://dealbook.nytimes.com/2012/05/17/agilent-technologies-to-buy-dako-for-2-2-billion/|title = Agilent to Buy Dako for $2.2 Billion|access-date = 2012-05-21|work = [[N. Y. Times|The New York Times]]|first = Mark|last = Scott|date = 17 May 2012|department = DealB%k|url-status = live|archive-url = https://web.archive.org/web/20120518090434/http://dealbook.nytimes.com/2012/05/17/agilent-technologies-to-buy-dako-for-2-2-billion/|archive-date = 18 May 2012}}</ref>

On September 19, 2013, Agilent announced its decision to separate into two publicly traded companies: Agilent, a life sciences, diagnostics, and applied markets company, and an electronic measurement company.<ref>{{Cite news|title=Agilent to spin off electronic measurement business|language=en|work=Reuters|url=https://www.reuters.com/article/us-agilent-spinoff-idUSBRE98I0IF20130919|access-date=2020-12-22}}</ref> The life sciences company retained the Agilent name and the electronic measurement company was called [[Keysight|Keysight Technologies]].<ref>{{Cite web|title=Agilent Technologies officially spins off e-measurement business Keysight|url=https://www.bizjournals.com/sacramento/blog/morning-roundup/2014/11/agilent-technologies-officially-spins-off-e.html|access-date=2020-12-22|website=www.bizjournals.com}}</ref> On October 14, 2014, the company announced that it is exiting its Nuclear Magnetic Resonance business.<ref>{{Cite web|last=Andy Extance2014-10-23T00:00:00+01:00|title=Agilent to exit NMR|url=https://www.chemistryworld.com/news/agilent-to-exit-nmr/7888.article|access-date=2020-12-22|website=Chemistry World|language=en}}</ref> On November 1, the formal separation of Agilent and [[Keysight Technologies]] was completed.<ref name=":4" /> Agilent announced it had completed the spin-off of its electronic measurement business, Keysight Technologies.<ref>{{cite web|url=https://about.keysight.com/en/companyinfo/history/|title=Company History - About Keysight|date=31 October 2017|website=about.keysight.com|access-date=3 May 2018|url-status=live|archive-url=https://web.archive.org/web/20180221161439/https://about.keysight.com/en/companyinfo/history/|archive-date=21 February 2018}}</ref>

In September 2015, the company announced it would acquire [[Seahorse Bioscience]] for $235 million.<ref>{{cite web|url=http://www.genengnews.com/gen-news-highlights/agilent-to-acquire-seahorse-bioscience-for-235m/81251713/ |title=Agilent to Acquire Seahorse Bioscience for $235M |date=9 September 2015 |access-date=2015-09-10 |url-status=live |archive-url=https://web.archive.org/web/20160427044942/http://www.genengnews.com/gen-news-highlights/agilent-to-acquire-seahorse-bioscience-for-235m/81251713 |archive-date=2016-04-27 }}</ref>

On July 7, 2016, Agilent announced that they had acquired U.K. based Cobalt Light Systems, which develops and manufactures [[Raman spectroscopy]] instruments, for £40 million in cash.<ref>{{Cite web|url=http://www.agilent.com/about/newsroom/presrel/2017/07jul-gp17014.html|title=Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems {{!}} Agilent|website=www.agilent.com|access-date=2017-11-02|url-status=live|archive-url=https://web.archive.org/web/20170922083216/http://www.agilent.com/about/newsroom/presrel/2017/07jul-gp17014.html|archive-date=2017-09-22}}</ref> In December the company acquired Multiplicom N.V.<ref>{{Cite web|url=https://www.biospace.com/article/releases/agilent-to-acquire-multiplicom-a-leading-european-diagnostics-company-with-state-of-the-art-genetic-testing-technology-and-products-/?s=79|title=Agilent to Acquire Multiplicom, A Leading European Diagnostics Company with State-Of-The-Art Genetic Testing Technology and Products|date=21 December 2016 }}</ref>

In January 2018, the company announced it would acquire Luxcel Biosciences, increasing the company's cell analysis portfolio.<ref>{{cite web|url=https://www.genengnews.com/gen-news-highlights/agilent-expands-cell-analysis-portfolio-with-luxcel-acquisition/81255357|title=Agilent Expands Cell Analysis Portfolio with Luxcel Acquisition - GEN|website=GEN|date=9 January 2018|url-status=live|archive-url=https://web.archive.org/web/20180110114656/https://www.genengnews.com/gen-news-highlights/agilent-expands-cell-analysis-portfolio-with-luxcel-acquisition/81255357|archive-date=2018-01-10}}</ref> In May, Agilent acquired Lasergen, Inc. after the end of its two-year option on a prior investment.<ref>{{Cite web|url=https://www.biospace.com/article/releases/agilent-completes-acquisition-of-lasergen-inc-/?s=79|title = Agilent Completes Acquisition of Lasergen, Inc| date=7 May 2018 }}</ref> In the same month it acquired digital laboratory management company, Genohm,<ref>{{Cite web|url=https://www.biospace.com/article/releases/agilent-completes-acquisition-of-genohm/?s=79|title=Agilent Completes Acquisition of Genohm|date=14 May 2018 }}</ref> Ultra Scientific, provider of chemical standards and reference materials<ref>{{Cite web|url=https://www.biospace.com/article/releases/agilent-technologies-to-acquire-assets-of-ultra-scientific/?s=79|title = Agilent Technologies to Acquire Assets of Ultra Scientific| date=30 May 2018 }}</ref> and Advanced Analytical Technologies, Inc. (AATI), provider of capillary [[electrophoresis]]-based molecules for $250 million in cash.<ref>{{Cite web|url=https://www.biospace.com/article/releases/agilent-technologies-completes-acquisition-of-advanced-analytical-technologies-inc-/?s=79|title = Agilent Technologies Completes Acquisition of Advanced Analytical Technologies, Inc| date=31 May 2018 }}</ref> In August the company announced it would acquire glycan reagent producer, ProZyme, Inc.<ref>{{Cite web|url=https://www.biospace.com/article/releases/agilent-technologies-completes-acquisition-of-prozyme/?s=79|title = Agilent Technologies Completes Acquisition of ProZyme| date=August 2018 }}</ref> and South Korean instrument distributor, Young In Scientific Co. Ltd.<ref>{{Cite web|url=https://www.biospace.com/article/releases/agilent-completes-acquisition-of-young-in-scientific-co-ltd-assets/?s=79|title=Agilent Completes Acquisition of Young in Scientific Co. LTD. Assets|date=17 August 2018 }}</ref> In September Agilent acquired ACEA Biosciences for $250 million increasing the company's presence in cell analysis technologies.<ref>{{Cite web|url=https://www.genengnews.com/gen-news-highlights/agilent-acquires-cell-analysis-tools-developer-acea-biosciences/81256276|title = Agilent Acquires Cell Analysis Tools Developer ACEA Biosciences|date = 26 September 2018}}</ref> In August 2019, Agilent acquired US-based BioTek Instruments, a designer, manufacturer, and distributor of life science instrumentation, for $1.165 billion.<ref>{{Cite web|url=https://www.nsmedicaldevices.com/news/agilent-technologies-biotek-instruments/|title=Agilent Technologies acquires US firm BioTek Instruments|date=2019-08-27|website=NS Medical Devices|language=en-US|access-date=2020-04-03}}</ref><ref>{{Cite web|url=https://www.biospectrumasia.com/news/83/14335/agilent-completes-acquisition-of-biotek-instruments.html|title=Agilent Completes Acquisition of BioTek Instruments|website=www.biospectrumasia.com|language=en|access-date=2020-04-03}}</ref>

On May 1, 2024, Padraig McDonnell succeeded Mike McMullen as CEO.<ref>{{Cite web |last=Tabeling |first=Katie |date=2024-03-07 |title=Agilent names veteran exec. McDonnell as next CEO |url=https://delawarebusinesstimes.com/news/new-castle-county/agilent-names-mcdonnell-ceo/ |access-date=2024-11-07 |website=Delaware Business Times |language=en-US}}</ref><ref>{{Cite web |date=3 May 2024 |title=Padraig McDonnell Named New CEO of Agilent Technologies |url=https://sliceofhealthcare.com/padraig-mcdonnell-named-new-ceo-of-agilent-technologies/ |access-date=2024-11-07 |website=sliceofhealthcare.com}}</ref>{{Portal|San Francisco Bay Area|Companies}}